irinotecan

You have access
CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
TOSHIAKI HAGIWARA, KIICHI SUGIMOTO, HIROTAKA MOMOSE, TAKAHIRO IRIE, KUMPEI HONJO, YU OKAZAWA, MASAYA KAWAI, SHINGO KAWANO, SHINYA MUNAKATA, MAKOTO TAKAHASHI, YUTAKA KOJIMA, NOBUKO SERIZAWA, AKIHITO NAGAHARA, ROBERT M. HOFFMAN, MALCOLM V. BROCK and KAZUHIRO SAKAMOTO

Anticancer Research February 2022, 42 (2) 697-707; DOI: https://doi.org/10.21873/anticanres.15528
You have access
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer
TOSHIHIRO TANAKA, MAKI TANAKA, HIDEMI FURUSAWA, YOSHIHIKO KAMADA, YOSHIAKI SAGARA, KEISEI ANAN, KYUICHIROU MIYARA, YUICHIROU KAI, TATSUYA UGA, KAZUO TAMURA, SHOSHU MITSUYAMA and KBC-SG (Kyushu Breast Cancer-Study Group)

Anticancer Research August 2020, 40 (8) 4779-4785; DOI: https://doi.org/10.21873/anticanres.14480
You have access
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN

Anticancer Research December 2019, 39 (12) 6463-6470; DOI: https://doi.org/10.21873/anticanres.13860
You have access
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ

Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104
You have access
Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen
RIYAD BENDARDAF, FATEMEH SAHEB SHARIF-ASKARI, NARJES SAHEB SHARIF-ASKARI, KARI SYRJÄNEN and SEPPO PYRHÖNEN

Anticancer Research November 2018, 38 (11) 6399-6404; DOI: https://doi.org/10.21873/anticanres.13000
You have access
Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms
YUICHI OZAWA, KEIGO KODA, DAISUKE AKAHORI, TAKASHI MATSUI, HIROTSUGU HASEGAWA, TAKUYA KAKUTANI, TUSUKE AMANO, MASAYUKI TANAHASHI, HIROSHI NIWA, YUKIHIRO KUNIMOTO, KAZUNARI YAMADA, KOSHI YOKOMURA and TAKAFUMI SUDA

Anticancer Research October 2018, 38 (10) 5937-5941; DOI: https://doi.org/10.21873/anticanres.12939
You have access
Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study
YI-HSIN LIANG, YU-YUN SHAO, HO-MIN CHEN, ANN-LII CHENG, MEI-SHU LAI and KUN-HUEI YEH

Anticancer Research December 2017, 37 (12) 7095-7104;
You have access
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab
BEATRIZ WILLS, ANDRÉS F. CARDONA, LEONARDO ROJAS, ALEJANDRO RUIZ-PATIÑO, OSCAR ARRIETA, NOEMÍ REGUART, HERNÁN CARRANZA, CARLOS VARGAS, JORGE OTERO, LUIS CORRALES, CLAUDIO MARTÍN, MAURICIO CUELLO, LUIS EDUARDO PINO, CHRISTIAN ROLFO, RAFAEL ROSELL, ZYANYA LUCIA ZATARAIN-BARRÓN and on behalf of The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

Anticancer Research November 2017, 37 (11) 6429-6436;
You have access
Control of Nausea and Vomiting in Patients with Colorectal Cancer Receiving Chemotherapy with Moderate Emetic Risk
AKIO SUZUKI, RYO KOBAYASHI, HIRONORI FUJII, HIROTOSHI IIHARA, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA and YOSHINORI ITOH

Anticancer Research December 2016, 36 (12) 6527-6533;
You have access
Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products
KEN-ICHI SAITO, YUTAKA INOUE, YOJI IKEGAMI, IZUMI NANBO, MARI ONOZUKA, KAZUMI SANO, HISAHIRO YOSHIDA, TOSHIHIRO SAKAMOTO, EMI TATEBAYASHI, KEN-ICHI FUJITA, YASUTSUNA SASAKI and TAKAKI KITAZAWA

Anticancer Research November 2016, 36 (11) 5957-5963;

Main menu

User menu

Search

irinotecan

Pages